All Blogs

Feb 22, 2018

The Business Cocktail : Latest Pharma deals


Feb 20, 2018

CRISPR to cure sickle cell; FDA rejected; Stem cells use; Celgene spinoff


Feb 19, 2018

Immune Checkpoint Activators (ICA): Dynamic Therapeutic Targets


Feb 16, 2018

Symdeko’s approval; Erytech target solid tumors; Oncologie snapped bavituximab; Merck delivers


Feb 14, 2018

Gilead Sciences Introduces Sovaldi: A Potent Hepatitis C Treatment


Feb 14, 2018

Business Cocktail


Feb 12, 2018

Natural Killer Cell Therapies: An Emerging Cellular Therapy


Feb 09, 2018

Involvement of B cells in the pathogenesis of primary Sjögren syndrome (pSS)


Feb 06, 2018

Notizia


Jan 30, 2018

Spasticity